| Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide M Gobbi, F Re, M Canovi, M Beeg, M Gregori, S Sesana, S Sonnino, ... Biomaterials 31 (25), 6519-6529, 2010 | 226 | 2010 |
| Nanotechnology for neurodegenerative disorders F Re, M Gregori, M Masserini Maturitas 73 (1), 45-51, 2012 | 210 | 2012 |
| Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model F Re, I Cambianica, C Zona, S Sesana, M Gregori, R Rigolio, B La Ferla, ... Nanomedicine: Nanotechnology, Biology and Medicine 7 (5), 551-559, 2011 | 198 | 2011 |
| Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models C Balducci, S Mancini, S Minniti, P La Vitola, M Zotti, G Sancini, M Mauri, ... Journal of Neuroscience 34 (42), 14022-14031, 2014 | 174 | 2014 |
| Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide M Taylor, S Moore, S Mourtas, A Niarakis, F Re, C Zona, B La Ferla, ... Nanomedicine: Nanotechnology, Biology and Medicine 7 (5), 541-550, 2011 | 172 | 2011 |
| Evolution of nanoparticle protein corona across the blood–brain barrier A Cox, P Andreozzi, R Dal Magro, F Fiordaliso, A Corbelli, L Talamini, ... ACS nano 12 (7), 7292-7300, 2018 | 161 | 2018 |
| Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of … L Bana, S Minniti, E Salvati, S Sesana, V Zambelli, A Cagnotto, A Orlando, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1583-1590, 2014 | 153 | 2014 |
| Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease F Re, C Airoldi, C Zona, M Masserini, BL Ferla, N Quattrocchi, F Nicotra Current medicinal chemistry 17 (27), 2990-3006, 2010 | 150 | 2010 |
| ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier R Dal Magro, F Ornaghi, I Cambianica, S Beretta, F Re, C Musicanti, ... Journal of Controlled Release 249, 103-110, 2017 | 139 | 2017 |
| Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model E Salvati, F Re, S Sesana, I Cambianica, G Sancini, M Masserini, ... International journal of nanomedicine, 1749-1758, 2013 | 124 | 2013 |
| Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide F Re, I Cambianica, S Sesana, E Salvati, A Cagnotto, M Salmona, ... Journal of biotechnology 156 (4), 341-346, 2011 | 124 | 2011 |
| Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model D Carradori, C Balducci, F Re, D Brambilla, B Le Droumaguet, O Flores, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (2), 609-618, 2018 | 117 | 2018 |
| Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi F Merli, S Luminari, A Tucci, A Arcari, L Rigacci, E Hawkes, CS Chiattone, ... Journal of clinical oncology 39 (11), 1214-1222, 2021 | 100 | 2021 |
| The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue M Canovi, E Markoutsa, AN Lazar, G Pampalakis, C Clemente, F Re, ... Biomaterials 32 (23), 5489-5497, 2011 | 99 | 2011 |
| Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice G Santamaria, E Brandi, PL Vitola, F Grandi, G Ferrara, F Pischiutta, ... Cell Death & Differentiation 28 (1), 203-218, 2021 | 86 | 2021 |
| Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice L Ordóñez-Gutiérrez, F Re, E Bereczki, E Ioja, M Gregori, AJ Andersen, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (2), 421-430, 2015 | 82 | 2015 |
| Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes M Canovi, J Lucchetti, M Stravalaci, F Re, D Moscatelli, P Bigini, ... Sensors 12 (12), 16420-16432, 2012 | 76 | 2012 |
| MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single … AJM Ferreri, JK Doorduijn, A Re, MG Cabras, J Smith, F Ilariucci, M Luppi, ... The Lancet Haematology 8 (2), e110-e121, 2021 | 70 | 2021 |
| The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease S Mancini, S Minniti, M Gregori, G Sancini, A Cagnotto, PO Couraud, ... Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 43-52, 2016 | 65 | 2016 |
| Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size-and time-dependent manner A Orlando, E Cazzaniga, M Tringali, F Gullo, A Becchetti, S Minniti, ... International Journal of Nanomedicine, 3547-3559, 2017 | 61 | 2017 |
